<DOC>
	<DOCNO>NCT00247702</DOCNO>
	<brief_summary>Oral warfarin anticogulation prevention treatment patient venous thromboembolism one use therapy clinical practice . Patients require different dosage achieve target therapeutic anticoagulation . Optimal dosage bleed complication two clinical concern . Besides multiple individual factor ( e.g . age , dietary intake , vitamin supplement , drug compliance etc . ) , genetic factor may determine drug requirement safety . The cytochrome P450 CYP2C9 liver enzyme required oxidative metabolism warfarin . The vitamin K epoxide redutase ( VKOR ) liver enzyme associate reuse oxidative hydroquinone form vitamin K. The VKOR enzyme target warfarin . Recent study reveal gene may determine pharmacodynamic warfarin anticogualation . To date , thirteen identify polymorphism CYP2C9 gene . Majority variant polymorphism may decrease warfarin requirement . The VKOR complex subunit 1 ( VKORC1 ) newly identify gene . Some polymorphism also report . As know , Chinese patient need low dosage warfarin comparison Caucasian patient . We interest find genetic cause Taiwneses Chinese patient . In study first identify polymorphism pattern two gene normal population . Then , try find association polymorphism patient warfarin requirement . Our pharmacogenetics study valuable prevention bleed complication warfarin treatment Chinese population .</brief_summary>
	<brief_title>The Association Warfarin Dosage Plasma Enantiomer Concentration With Gene Polymorphisms CYP VKOR</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Use warfarin therapy least two month study Stable INR value recent three month high age ( &gt; 80 y/o ) liver renal dysfunction alcohol abuse BMI &lt; 18kg/m2 coadministered medicine affect pharmacokinetics pharmacodynamics warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>CYP2C9</keyword>
	<keyword>VKORC1</keyword>
	<keyword>polymorphism</keyword>
	<keyword>warfarin</keyword>
</DOC>